Jennifer Dienes

Jennifer Dienes

Morgan Lewis

Contact
View Bio
RSS

Latest Posts › Draft Guidance

Share:

What’s in a Name? FDA Proposes Updates to Its Biosimilar Naming Policy

The US Food and Drug Administration (FDA) issued an updated draft guidance on March 7 on the nonproprietary naming of biologics, titled Nonproprietary Naming of Biological Products: Update (Guidance). This update is FDA’s...more

3/18/2019  /  Biosimilars , Draft Guidance , Food and Drug Administration (FDA) , Life Sciences
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide